Sami Karaborni

Dr. Karaborni joined Teon in 2019 as consulting Head of Drug Development. He is an expert in product and process development of new chemical entities (NCEs) and various dosage forms. Over his 30-year career he served in several senior executive positions including Vice President of Development Operations and Executive Director of Preformulation and Formulation Development at XenoPort Inc. At XenoPort, he led multiple groups active in the areas of chemical, analytical, bioanalytical, formulation development, supply chain and commercial manufacturing. He was Director of Pre-clinical Development Technology, Director of Materials Characterization and Technology Assessment, and Director of Formulation Design and Characterization at Merck Research Labs. In his early career, he was Senior Research Engineer for the Royal Dutch Shell company in Amsterdam, The Netherlands.

Dr. Karaborni is a member of the advisory board of the Surfactant Science series and inventor of more than 20 US published patents and patent applications. Sami is the (co)author of more than 40 publications in international journals among which Science (Washington), Nature (London), La Recherche Scientifique (Paris) and Mundo Científico (Madrid). He has been a key speaker in several conferences among which Gordon Conferences (USA), Royal Society of Chemistry (Great Britain) and Rencontres de Moriond (Switzerland).